Stay updated on InMed Pharmaceuticals Press Releases
Sign up to get notified when there's something new on the InMed Pharmaceuticals Press Releases page.

Latest updates to the InMed Pharmaceuticals Press Releases page
- Check4 days agoChange DetectedThe press release list adds an October 26, 2026 announcement about the CVR distribution record date tied to InMed’s proposed merger, while the September 23, 2025 fiscal-year results release is no longer displayed.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check45 days agoChange DetectedA new press release entry dated September 18, 2026 about Nasdaq notification regarding minimum shareholders' equity compliance was added to the press releases list, signaling a regulatory update for investors. An older press release about presenting at the Life Sciences Virtual Investor Forum on September 18, 2025 was removed from the listing.SummaryDifference1%

- Check52 days agoChange DetectedA new press release entry dated September 9, 2026, InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate Update, was added to the press releases list. A previous entry about participating in the H.C. Wainwright conference on September 5, 2025 was removed.SummaryDifference1%

- Check117 days agoChange DetectedAn item announcing a merger amendment with Mentari Therapeutics and the filing of a Form S-4 was added. An older press release about INM-901 data at AAIC 2025 was removed.SummaryDifference1%

- Check152 days agoChange DetectedAdded a June 4, 2026 press release announcing Nasdaq listing compliance. Removed a June 27, 2025 private placement press release from the investor news list.SummaryDifference1%

- Check167 days agoChange DetectedAdded two new press releases: 'InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies' (May 19, 2026) and 'InMed Pharmaceuticals Amends Preferred Investment Options'. Removed two older items: 'InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules' (June 25, 2025) and 'InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study' (June 24, 2025).SummaryDifference7%

Stay in the know with updates to InMed Pharmaceuticals Press Releases
Enter your email address, and we'll notify you when there's something new on the InMed Pharmaceuticals Press Releases page.